C
Carrie L. Moland Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
High Impact
Researcher
faculty
28 h-index
47 pubs
3,367 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Carrie L. Moland's research investigates the mechanisms of drug-induced cardiotoxicity, with a specific focus on doxorubicin. Her work explores delayed-onset subclinical cardiotoxicity and the potential of circulating microRNAs, such as microRNA-34a-5p, as early preclinical biomarkers for chronic cardiotoxicity. Moland's studies also examine sex-related differences in cardiotoxicity induced by doxorubicin, investigating the role of pathways like the apelin-APJ system.
Her research has involved studies in male and female mice and rats, utilizing gene expression profiling to understand molecular responses. Moland has published 47 papers, accumulating over 3,349 citations, and holds an h-index of 28. She is recognized as a highly cited researcher. Her collaborations include work with Vikrant Vijay, James C. Fuscoe, and Bounleut Phanavanh at the National Center for Toxicological Research, as well as Kimo C. Stine at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 28
- Publications: 47
- Citations: 3,367
Selected Publications
-
Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice (2022)
-
MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity (2022)
-
Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice (2021)
Collaboration Network
Top Collaborators
Varsha G. Desai
National Center for Toxicological Research (US)
3 shared publications
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Vikrant Vijay
United States Food and Drug Administration
3 shared publications
In database
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Tao Han
National Center for Toxicological Research (US)
3 shared publications
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Bounleut Phanavanh
National Center for Toxicological Research
3 shared publications
In database
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
James C. Fuscoe
United States Food and Drug Administration
3 shared publications
In database
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Taewon Lee
Department of Mathematical Sciences (RU)
2 shared publications
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
Kimo C. Stine
Arkansas Children's Hospital
2 shared publications
In database
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
Kelly J. Davis
National Center for Toxicological Research (US)
1 shared publication
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
Levan Muskhelishvili
National Center for Toxicological Research (US)
1 shared publication
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
Eugene H. Herman
National Cancer Institute (MY)
1 shared publication
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
Ana Clara P. Azevedo‐Pouly
National Center for Toxicological Research
1 shared publication
In database
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Javier R. Revollo
United States Food and Drug Administration
1 shared publication
In database
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Baikuntha Aryal
Center for Drug Evaluation and Research (US)
1 shared publication
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
V. Ashutosh Rao
United States Food and Drug Administration (US)
1 shared publication
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Similar Researchers
Based on overlapping research topics
James C. Fuscoe
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Cardiovascular Function and Risk Factors
Molecular Biology Techniques and Applications
Sayed Hasan
University of Arkansas for Medical Sciences
Cardiovascular Function and Risk Factors
Molecular Biology Techniques and Applications
Gene expression and cancer classification
Bounleut Phanavanh
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Cardiovascular Function and Risk Factors
MicroRNA in disease regulation
Bridgett Knox
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Molecular Biology Techniques and Applications
MicroRNA in disease regulation
Yuxi Li
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Molecular Biology Techniques and Applications
Disease Mechanisms Research
Vikrant Vijay
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Cardiovascular Function and Risk Factors
Molecular Biology Techniques and Applications